NLRP3 and Hepatic fibrosis: A438079, a specific inhibitor of P2X7 that acts as a trigger for NLRP3 inflammasomes, attenuates CCL4-induced hepatic fibrosis in mice by downregulating smooth muscle α-actin and TGF-β1 expression and reducing hepatic collagen formation [23].